CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.890 |
Evidence |
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
22.890 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
22.890 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CD2AP |
CD2AP: CD2-associated protein |
22.890 |
Evidence |
|
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
22.890 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
22.890 |
Evidence |
|
CTSG |
CTSG: Cathepsin G precursor |
CMA1 |
CMA1, CYH, CYM: Chymase precursor |
22.890 |
Evidence |
|
PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
CRKL |
CRKL: Crk-like protein |
22.890 |
Evidence |
|
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.890 |
Evidence |
|
PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
22.870 |
Evidence |
|
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
CDH9 |
IPI00655756 |
22.840 |
Evidence |
|
DEDD |
DEDD, DEDPRO1, KE05, DEFT: Death effector domain-containing protein |
DDX58 |
DDX58: Probable ATP-dependent RNA helicase DDX58 |
22.840 |
Evidence |
|
CDH8 |
CDH8: Cadherin-8 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
22.840 |
Evidence |
|
DSG1 |
DSG1: Desmoglein-1 precursor |
PKP3 |
PKP3: Plakophilin-3 |
22.840 |
Evidence |
|
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
22.840 |
Evidence |
|
TNFRSF21 |
TNFRSF21, DR6, UNQ437/PRO868: Tumor necrosis factor receptor superfamily member |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
22.840 |
Evidence |
|
MYB |
MYB: Myb proto-oncogene protein |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
22.790 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
22.790 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
22.790 |
Evidence |
|
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
22.790 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
22.790 |
Evidence |
|
ETS2 |
ETS2: Protein C-ets-2 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
22.790 |
Evidence |
|
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
DSG2 |
DSG2: Desmoglein-2 precursor |
22.790 |
Evidence |
|
C1R |
C1R: Complement C1r subcomponent precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
22.790 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
22.790 |
Evidence |
|